Knowing stock market today at a glance

Bull&Bear | Diginex Leads Bullish Surge with 234.56% Gain; YIBO International Plummets 29.77%

Mover TrackerWednesday, Jan 29, 2025 5:00 pm ET

1min read

In the realm of bullish stocks, Diginex (DGNX) has seen an impressive surge of 234.56%, marking a three-day increase of 486.55%. The Hong Kong-based company successfully completed its IPO in the United States, with its share price increasing 2.1 times over the span of just two days.

Ranpak Holdings (PACK) saw a significant rise of 47.21% in its share price, largely driven by the announcement of a deal with Amazon, which fueled investor enthusiasm and resulted in a sharp spike in the company's stocks.

WYHG, operating under the renowned Guangdong food brand Rongye Foods, experienced a 28.47% increase. The traditional preserved meat company, which grosses an annual revenue of 1 billion yuan, is embarking on a new journey after going public in the United States.

Skye Bioscience (SKYE) marked a 27.04% increase, maintaining its upward momentum for the past two days with a total gain of 32.43%. The biotechnology firm is set to participate in an upcoming healthcare investment conference in December, which has likely contributed to the recent stock performance.

Nextracker (NXT) observed a rise of 24.28%. The company's stock was upgraded to an "overweight" rating by Barclays, citing "flawless execution" as a primary reason for the improved outlook.

In the realm of bearish stocks, YIBO International (YIBO) saw a substantial decline of 29.77%. The company's stock began its descent following the release of a report detailing a year-over-year drop in sales performance for the first half of the year.

Bakkt Holdings (BKKT) experienced a notable decline of 28.41%. This came after NINGI Research publicly announced that it was shorting Bakkt Holdings. Their stance was grounded in the belief that any potential acquisition of Bakkt Holdings would be unlikely due to its partnership with Charles Schwab.

Manhattan Associates (MANH) faced a drop of 24.49%, spurred by 2025 fiscal guidance that fell short of market expectations, leading to a significant slump in their stock price.

Zentalis Pharmaceuticals (ZNTL) suffered a loss of 21.25%. The company's decision to lay off 40% of its workforce triggered a sharp decline in its stock, as investors reacted to the cost-cutting measures.

Globalstar (GSAT) saw an 18.06% fall. The decline in share price followed Apple's latest iPhone update, which now supports SpaceX's Starlink service, posing competitive pressures on Globalstar's market position.

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.